Drugs / PfSPZ-GA1 Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03163121 | May 2017 → Oct 2018 | malaria | Sanaria Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PfSPZ-GA1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163121 ↗ |
| Modality | Vaccine | “PfSPZ-GA1 Vaccine (genetically attenuated PfSPZ)” NCT03163121 ↗ |
| Route | Intravenous | “direct venous inoculation (DVI)” NCT03163121 ↗ |